Contact Congress about S. 3345: PBM Price Transparency and Accountability Act

The bill would ban spread pricing in Medicaid and make PBM payment rules more transparent in Medicaid and Medicare Part D. It would also set new standards for pharmacy contracts and access in Medicare drug plans. PBMs, plans, states, and pharmacies would all face new reporting, audit, and enforcement rules.

Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

PBM Price Transparency and Accountability Act is a Senate bill in committee. The latest recorded action: Read twice and referred to the Committee on Finance.

Latest action on S. 3345: Read twice and referred to the Committee on Finance.

Who this affects: This bill mainly affects independent pharmacies, rural pharmacies, PBMs, Medicare drug plans, and state Medicaid programs. Medicare Part D patients could also feel the effects if plan networks change or if local pharmacies get stronger protections. Federal regulators would take on a bigger role because they would set standards, collect data, investigate complaints, and enforce the new rules.

Why this matters: This bill matters because it could change who keeps money inside the prescription drug system and how visible those payments are. Today, states and plans may not fully see how PBMs, pharmacies, rebates, and fees interact. The bill tries to make those flows clearer, tie some payments more closely to real drug costs, and protect access to local pharmacies. It could shift money away from hidden margins and toward more direct payment rules, but the final effect on costs and patient access would still depend on how plans, PBMs, states, and regulators act.

Key provisions in S. 3345

• Pharmacies would have to answer monthly national surveys about what they pay to buy drugs. That applies to retail pharmacies and some non-retail pharmacies, and refusing could bring civil fines of up to $100,000 for each violation.
• HHS would have to publish summary results from those drug cost surveys. The public release must include response rates, sampling methods, and overall data on pharmacy price concessions.
• States could not use non-retail pharmacy price data to set payment rules for retail community pharmacies. Retail payment methods would have to rely on retail pharmacy data instead.
• Medicaid contracts with managed care plans and PBMs would have to use a transparent pass-through model. Drug payment could cover only ingredient cost plus a professional dispensing fee, and spread pricing would not count for federal matching funds.
• PBMs and health plans in Medicaid could charge only fair-market-value administrative fees. They would also have to fully disclose drug costs, fees, discounts, and other payments to states and, if asked, to HHS.

How Modern Action helps you take action on S. 3345

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about S. 3345

What is S. 3345?

The bill would ban spread pricing in Medicaid and make PBM payment rules more transparent in Medicaid and Medicare Part D. It would also set new standards for pharmacy contracts and access in Medicare drug plans. PBMs, plans, states, and pharmacies would all face new reporting, audit, and enforcement rules.

How do I support or oppose S. 3345?

Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.

Who should I contact about S. 3345?

Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.

Can Modern Action explain S. 3345 before I act?

Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.